Molmir Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $1.88M

  • Investors
  • 9

Molmir General Information

Description

Developer of a molecular detection method designed to discover new drugs. The company develops treatments for intractable diseases based on sensing technology that senses the movement and state of molecules and utilizes chemical tongue and nuclear magnetic resonance at the atomic level, enabling doctors to treat rare diseases.

Contact Information

Website
www.molmir.co.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 840 Shijo-cho
  • Kashihara, Nara
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 840 Shijo-cho
  • Kashihara, Nara
  • Japan

Molmir Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Molmir Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) 22-Apr-2026 $1.88M Completed Generating Revenue
5. Accelerator/Incubator 03-Sep-2025 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Seed Round 24-May-2024 $771K $771K Completed Generating Revenue
1. Seed Round 24-Dec-2022 Completed Generating Revenue
To view Molmir’s complete valuation and funding history, request access »

Molmir Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class B preferred
Class A Preferred
To view Molmir’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Molmir Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Molmir Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4306543-A1 Anti-adamts13 antibody and use thereof Pending 05-Mar-2021
EP-4306543-A4 Anti-adamts13 antibody and use thereof Pending 05-Mar-2021
US-12617869-B2 Anti-adamts13 antibody and use thereof Active 05-Mar-2021
US-20240425614-A1 Anti-adamts13 antibody and use thereof Active 05-Mar-2021 C07K16/40

Molmir Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Molmir Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
BP Capital (Japan) PE/Buyout Minority
Higin Capital Investment Bank Minority
Nanto Capital Partners Corporate Venture Capital Minority
MEDISO Accelerator/Incubator
Tech Planter Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Molmir FAQs

  • When was Molmir founded?

    Molmir was founded in 2022.

  • Where is Molmir headquartered?

    Molmir is headquartered in Kashihara, Japan.

  • What is the size of Molmir?

    Molmir has 2 total employees.

  • What industry is Molmir in?

    Molmir’s primary industry is Drug Discovery.

  • Is Molmir a private or public company?

    Molmir is a Private company.

  • What is the current valuation of Molmir?

    The current valuation of Molmir is .

  • What is Molmir’s current revenue?

    The current revenue for Molmir is .

  • How much funding has Molmir raised over time?

    Molmir has raised $2.65M.

  • Who are Molmir’s investors?

    BP Capital (Japan), Higin Capital, Nanto Capital Partners, MEDISO, and Tech Planter are 5 of 9 investors who have invested in Molmir.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process